REDUCED ORAL ETOPOSIDE BIOAVAILABILITY IN PATIENTS WITH ADVANCED CANCER OF THE HEAD AND NECK

被引：9

作者：

DESOIZE, B

WOIRIN, V

LEGROS, M

CONINX, P

机构：

[1] JOINT COMM HEAD & NECK CANC,REIMS,FRANCE

[2] INST JEAN GODINOI,PHARMACOL LAB,F-51056 REIMS,FRANCE

[3] HOP ROBERT DEBRE,SERV OTORHINOLARYNOL,REIMS,FRANCE

[4] INST JEAN GODINOI,SERV MED ONCOL,F-51056 REIMS,FRANCE

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1992年 / 84卷 / 05期

关键词：

D O I：

10.1093/jnci/84.5.348

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：348 / 350

页数：3

共 16 条

[1] THE CLINICAL-PHARMACOLOGY OF ETOPOSIDE AND TENIPOSIDE [J].

CLARK, PI ;

SLEVIN, ML .

CLINICAL PHARMACOKINETICS, 1987, 12 (04) :223-252

[2]

CONINX P, 1986, B CANCER, V73, P85

[3]

CONINX P, 1988, CANCER, V62, P1888, DOI 10.1002/1097-0142(19881101)62:9<1888::AID-CNCR2820620903>3.0.CO

[4]

2-M

[5] PILOT-STUDY OF A CONTINUOUS 5-DAY INTRAVENOUS-INFUSION OF ETOPOSIDE CONCOMITANT WITH CISPLATIN IN SELECTED PATIENTS WITH ADVANCED CANCER [J].

CREAGAN, ET ;

RICHARDSON, RL ;

KOVACH, JS .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (07) :1197-1201

[6]

CUNNINGHAM D, 1986, MED ONCOL TUMOR PHAR, V3, P95

[7] CLINICAL PHARMACOKINETICS OF ETOPOSIDE DURING 120 HOURS CONTINUOUS INFUSIONS IN SOLID TUMORS [J].

DESOIZE, B ;

MARECHAL, F ;

CATTAN, A .

BRITISH JOURNAL OF CANCER, 1990, 62 (05) :840-841

[8]

DINCALCI M, 1982, CANCER CHEMOTH PHARM, V7, P141

[9]

DINCALCI M, 1982, P AM ASSOC CANC RES, V23, P131

[10]

DURAND RE, 1987, CANCER TREAT REP, V71, P673

← 1 2 →